688626 翔宇医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.76011.3056.49715.07530.410
总资产报酬率 ROA (%)2.1589.1595.51412.76223.014
投入资产回报率 ROIC (%)2.47010.4686.11514.17423.762

边际利润分析
销售毛利率 (%)68.21968.62166.27468.23067.753
营业利润率 (%)18.15232.84527.72942.80145.074
息税前利润/营业总收入 (%)14.75428.76121.76937.96542.419
净利润/营业总收入 (%)16.75030.65425.23838.11739.557

收益指标分析
经营活动净收益/利润总额(%)85.92688.16556.02673.95478.259
价值变动净收益/利润总额(%)2.1893.80810.2655.444-0.139
营业外收支净额/利润总额(%)-0.346-0.245-1.858-0.601-0.253

偿债能力分析
流动比率 (X)2.0913.2094.7429.4623.357
速动比率 (X)1.6172.5614.1098.5832.706
资产负债率 (%)23.60118.69918.08310.85724.273
带息债务/全部投入资本 (%)9.4221.6584.5370.675--
股东权益/带息债务 (%)911.1635,627.7522,023.87014,295.4611,181.688
股东权益/负债合计 (%)321.088431.387450.141816.587312.079
利息保障倍数 (X)-4.422-7.185-3.992-8.289-16.692

营运能力分析
应收账款周转天数 (天)30.42320.64026.80124.0500.000
存货周转天数 (天)407.449357.501417.574313.3670.000